Skip to main content

Table 1 Protein identification using MALDI-TOF MS/MS

From: Screening for immune-potentiating antigens from hepatocellular carcinoma patients after radiofrequency ablation by serum proteomic analysis

No.

gi|

Protein name

A01

251,837,060

Chain D, Cobra Venom Factor (Cvf) In Complex With Human Factor B

A02

110,590,599

Chain A, Apo-Human Serum Transferrin (Glycosylated)

A04

78,174,390

HP protein

A05

220,702,427

Chain B, Crystal Structure Of Bbetad432a Variant Fibrinogen Fragment D With The Peptide Ligand Gly-His-Arg-Pro-Amide

A06

7,770,217

PRO2675

A07

49,258,810

Chain A, Human Serum Transferrin, N-Lobe Bound With Oxalate

A09

158,254,550

unnamed protein product

A10

193,787,502

unnamed protein product

A12

32,891,795

clusterin (complement lysis inhibitor, SP-40,40, sulfated glycoprotein 2, testosterone-repressed prostate message 2, apolipoprotein J)

A13

86,439,006

immunoglobulin lambda light chain

A17

7,770,173

PRO2222 (RBP4)

A18

212,374,952

Chain A, Crystal Structure Of Transthyretin Variant V20 s

B02

2,781,209

Chain C, Crystal Structure Of Fibrinogen Fragment D

B10

3,413,516

Hakata antigen (H-ficolin)

B11

119,626,073

albumin, isoform CRA_j

B12

576,259

Chain A, The Structure Of Pentameric Human Serum Amyloid P Component

B13

149,673,887

immunoglobulin light chain

B14

170,684,606

immunoglobulin kappa 1 light chain